treatment of lymphocytes with okm1 together with okt11a and c decreased nk cell activity against 3 nk-sensitive leukemia lines -- k562 , molt-4 , and hsb-2 -- more than did treatment with either antibody alone ;
C0024264
lymphocytes
C1292777
nk cell